Brad Hively
InvestorAdvisor at Oncology Ventures Β· Investor at M33 Growth
Los Angeles, California, United States
About
Former CEO and current Vice Chairman of The Oncology Institute (NASDAQ: TOI), which he led through its 2021 public listing. Previously a healthcare investor at TA Associates, General Atlantic, and RLH Equity.
Experience
- US Neurology AssociatesChairman and Co-Foundercurrent2025 β present
- The Oncology InstituteVice Chairman, Board of Directorscurrent2023 β presentGreater Los Angeles, California, United States
- The Oncology InstituteChief Executive Officer2019 β 2023Greater Los Angeles Area
- The Oncology InstituteInvestor / Board Member2018 β 2019
- Commons ClinicBoard of Directorscurrent2024 β present
- OrthoNebraskaBoard of Directors, Audit Committee Chaircurrent2024 β present
- Unio Health PartnersBoard of Directorscurrent2023 β presentCalifornia, United States
- Unio Health PartnersInterim Chief Executive Officer2023 β 2024
- Clara Care, Inc.Board of Directorscurrent2024 β present
- Oncology VenturesAdvisory Boardcurrent2026 β present
- RLH Equity PartnersStrategic Advisorcurrent2013 β presentLos Angeles
- University of Southern CaliforniaAdjunct Faculty, USC Price School of Public Policycurrent2010 β present
- YPOMembercurrent2020 β present
- HealthEssentials, LLCPresident2014 β 2016Los Angeles
- Heritage Provider NetworkSenior Vice President, Medical Group Operations2009 β 2014
- General Atlantic, LLCSenior Associate2008Palo Alto
- TA AssociatesAssociate (Healthcare Group)2004 β 2007Boston
- Merrill Lynch - Healthcare Investment BankingAnalyst2000 β 2004New York & Los Angeles
Education
- Stanford University Graduate School of BusinessMBA
- UCLABA, Economics
Skills & more
Healthcare ManagementManaged CarePhysiciansPrivate EquityCorporate DevelopmentStart-upsValuationDue DiligenceFinancial AnalysisCorporate FinanceEntrepreneurshipBusiness Strategy
+12 more
Competitive AnalysisInvestmentsBusiness DevelopmentHealthcareInvestment BankingHealthcare Information TechnologyHealthcare ConsultingHealthcare IndustryStrategyStrategic PlanningPharmaceutical IndustryStrategic PartnershipsFrom Brad's professional profile.
Same school
Also attended Stanford University Graduate School of Business1,147
Roelof BothaAdvisor & former Steward at Sequoia Capital; SpaceX board memberPeter FentonGeneral Partner at BenchmarkSteve JurvetsonCo-founder of Future VenturesDavid SzeAdvisory Partner at GreylockKatherine BoyleGeneral Partner at Andreessen Horowitz (American Dynamism)Hunter WalkCo-founder & Partner at Homebrew
+ 1,141 more
Also attended UCLA374
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzRon ConwayFounder of SV AngelKirsten GreenFounder and Managing Partner at Forerunner VenturesPaul FieldingFinance & Operations at General CatalystMelody MaExecutive Assistant and Lead Receptionist at Trinity VenturesGizem CakilInvestor at OpenView Venture Partners
+ 368 more
Shared employers
Also worked at US Neurology Associates2
Also worked at RLH Equity Partners5
Also worked at General Atlantic, LLC109
Adrianna MaInvestor at Index VenturesJan HammerInvestor at Index VenturesJimena NowackInvestor at Index VenturesJin-Young KimInvestment Team at 8VCDan CahanaInvestor at GGV CapitalLauren LeeInvestor at FJ Labs
+ 103 more
Also worked at Merrill Lynch - Healthcare Investment Banking397
Hans TungManaging Partner at Notable CapitalAnthony LinHead of Intel Capital, Corporate Vice President at Intel CapitalNoorPartner at Clear VenturesKesha CashFounder & General Partner at Impact America FundAftab MathurManaging Director at Temasek at Golden Gate VenturesAndrew WallaceVice President, Revolution Growth at Revolution
+ 391 more
Colleagues at Oncology Ventures
Ben Freeberg
Founder, Managing Partner at Oncology Ventures
Carolyn Starrett
Advisor at Oncology Ventures
David Cohn
Interim Chief Executive Officer and Chief Medical Officer at Oncology Ventures
Diana Verrilli
General Manager, Navista (a Cardinal Health company) at Oncology Ventures
Emily Melton
Investor at Threshold Ventures
Harlan Levine
President of Health Innovation and Policy at Oncology Ventures
Jason Shook
Chief Operating Officer at Oncology Ventures
Jay Freeberg
Chief Financial Officer at Oncology Ventures















.jpg)


%20(1).png)








